ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

Moderna CEO eyes producing COVID vaccine in Asia

Bancel reveals the company is in talks with possible Japanese partners

For vaccine production in Japan, there is a possibility that Moderna will seek consignment contracts or license agreements with Japanese companies.   © Reuters

NEW YORK -- Moderna is considering manufacturing its coronavirus vaccine in Japan, with chief executive Stephane Bancel telling Nikkei in a phone interview, "We're having discussions in several countries in Asia, including Japan."

The news comes soon after the Japanese health ministry officially approved the manufacture and sale of the vaccines developed by Moderna and AstraZeneca on Friday.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more